318 related articles for article (PubMed ID: 11499868)
1. Reconstituting telomerase activity using the telomerase catalytic subunit prevents the telomere shorting and replicative senescence in human osteoblasts.
Yudoh K; Matsuno H; Nakazawa F; Katayama R; Kimura T
J Bone Miner Res; 2001 Aug; 16(8):1453-64. PubMed ID: 11499868
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between periarticular osteoporosis and osteoblast senescence in patients with rheumatoid arthritis].
Yudoh K; Matsuno H; Kimura T
Clin Calcium; 2001 May; 11(5):612-8. PubMed ID: 15775563
[TBL] [Abstract][Full Text] [Related]
3. Decreased cellular activity and replicative capacity of osteoblastic cells isolated from the periarticular bone of rheumatoid arthritis patients compared with osteoarthritis patients.
Yudoh K; Matsuno H; Osada R; Nakazawa F; Katayama R; Kimura T
Arthritis Rheum; 2000 Oct; 43(10):2178-88. PubMed ID: 11037877
[TBL] [Abstract][Full Text] [Related]
4. Telomerized presenescent osteoblasts prevent bone mass loss in vivo.
Yudoh K; Nishioka K
Gene Ther; 2004 Jun; 11(11):909-15. PubMed ID: 15057262
[TBL] [Abstract][Full Text] [Related]
5. Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation.
MacKenzie KL; Franco S; May C; Sadelain M; Moore MA
Exp Cell Res; 2000 Sep; 259(2):336-50. PubMed ID: 10964501
[TBL] [Abstract][Full Text] [Related]
6. Immortalization of human osteoblasts by transferring human telomerase reverse transcriptase gene.
Xiaoxue Y; Zhongqiang C; Zhaoqing G; Gengting D; Qingjun M; Shenwu W
Biochem Biophys Res Commun; 2004 Mar; 315(3):643-51. PubMed ID: 14975749
[TBL] [Abstract][Full Text] [Related]
7. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
[TBL] [Abstract][Full Text] [Related]
8. Senescence occurs with hTERT repression and limited telomere shortening in human oral keratinocytes cultured with feeder cells.
Kang MK; Kameta A; Shin KH; Baluda MA; Park NH
J Cell Physiol; 2004 Jun; 199(3):364-70. PubMed ID: 15095283
[TBL] [Abstract][Full Text] [Related]
9. Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells.
Huang JJ; Lin MC; Bai YX; Jing DD; Wong BC; Han SW; Lin J; Xu B; Huang CF; Kung HF
Cancer Res; 2002 Jun; 62(11):3226-32. PubMed ID: 12036938
[TBL] [Abstract][Full Text] [Related]
10. Events in the immortalizing process of primary human mammary epithelial cells by the catalytic subunit of human telomerase.
Kim H; Farris J; Christman SA; Kong BW; Foster LK; O'Grady SM; Foster DN
Biochem J; 2002 Aug; 365(Pt 3):765-72. PubMed ID: 11978176
[TBL] [Abstract][Full Text] [Related]
11. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
[TBL] [Abstract][Full Text] [Related]
12. Telomerase-immortalized sheep fibroblasts can be reprogrammed by nuclear transfer to undergo early development.
Cui W; Wylie D; Aslam S; Dinnyes A; King T; Wilmut I; Clark AJ
Biol Reprod; 2003 Jul; 69(1):15-21. PubMed ID: 12606403
[TBL] [Abstract][Full Text] [Related]
13. Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization.
Di Donna S; Mamchaoui K; Cooper RN; Seigneurin-Venin S; Tremblay J; Butler-Browne GS; Mouly V
Mol Cancer Res; 2003 Jul; 1(9):643-53. PubMed ID: 12861050
[TBL] [Abstract][Full Text] [Related]
14. Use of telomerase to create bioengineered tissues.
Shay JW; Wright WE
Ann N Y Acad Sci; 2005 Dec; 1057():479-91. PubMed ID: 16399914
[TBL] [Abstract][Full Text] [Related]
15. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells.
Simonsen JL; Rosada C; Serakinci N; Justesen J; Stenderup K; Rattan SI; Jensen TG; Kassem M
Nat Biotechnol; 2002 Jun; 20(6):592-6. PubMed ID: 12042863
[TBL] [Abstract][Full Text] [Related]
16. Transient expression of human telomerase extends the life span of normal human fibroblasts.
Steinert S; Shay JW; Wright WE
Biochem Biophys Res Commun; 2000 Jul; 273(3):1095-8. PubMed ID: 10891377
[TBL] [Abstract][Full Text] [Related]
17. Effects of telomerase modulation in human hematopoietic progenitor cells.
Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
[TBL] [Abstract][Full Text] [Related]
18. Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential.
Wege H; Le HT; Chui MS; Liu L; Wu J; Giri R; Malhi H; Sappal BS; Kumaran V; Gupta S; Zern MA
Gastroenterology; 2003 Feb; 124(2):432-44. PubMed ID: 12557149
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.
Ulaner GA; Hu JF; Vu TH; Giudice LC; Hoffman AR
Cancer Res; 1998 Sep; 58(18):4168-72. PubMed ID: 9751630
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
